Viewing Study NCT01992705


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2026-03-12 @ 11:38 AM
Study NCT ID: NCT01992705
Status: COMPLETED
Last Update Posted: 2019-08-19
First Post: 2013-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Borderline Pancreas Study: FOLFIRINOX +SBRT
Sponsor: University of Maryland, Baltimore
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Resectable Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pancreatic cancer View